work
describ
applic
thermophil
microorgan
obtain
purin
nucleosid
biosynthesi
deoxyribosid
ribosid
achiev
geobacillu
stearothermophilu
cect
convers
respect
furthermor
select
microorgan
satisfactorili
stabil
immobil
agaros
matrix
biocatalyst
reus
least
time
without
signific
loss
activ
obtain
mgl
deoxyribosid
obtain
compound
use
antivir
agent
known
purin
nucleosid
deriv
play
import
role
antivir
therapi
activ
deoxyribosid
ribosid
hepat
c
viru
hcv
sar
coronaviru
sar
cov
alreadi
demonstr
moreov
antitumor
activ
ribosid
assay
leukem
cell
nucleosid
analogu
princip
synthes
chemic
method
method
requir
organ
solvent
multipl
reaction
step
remov
protect
group
yield
undesir
racem
mixtur
decreas
convers
affect
product
purif
howev
biocatalysi
emerg
altern
drawback
owe
high
catalyt
effici
inher
select
simpl
downstream
process
biosynthesi
purin
nucleosid
transglycosyl
use
microorgan
previous
report
reaction
perform
stereoselect
nucleosid
phosphorylas
np
enzym
thermophil
microorgan
sourc
enzym
extrem
stabil
applic
microorgan
biocatalyst
attract
industri
bioprocess
microorgan
stabil
immobil
techniqu
good
method
carri
biotransform
allow
high
oper
stabil
easi
upstream
separ
bioprocess
scaleup
feasibl
cell
entrap
techniqu
wide
use
whole
cell
immobil
present
work
describ
effici
onepot
biosynthesi
purin
nucleosid
use
smooth
cheap
environment
friendli
methodolog
compound
use
antivir
compound
prodrug
antileukem
agent
abil
geobacillu
stearothermophilu
hydrolyz
uridin
urd
thymidin
dthd
evalu
order
identifi
optim
strain
purin
nucleosid
biosynthesi
fig
g
stearothermophilu
cect
show
highest
activ
nucleosid
test
hydrolysi
quantit
evalu
hplc
analysi
perform
nucleodur
column
lm
mm
mm
use
uv
detector
nm
column
oper
use
isocrat
mobil
phase
watermethanol
vv
flow
rate
mlmin
hydrolysi
sugar
donor
evalu
fig
g
stearothermophilu
cect
abl
hydrolyz
durd
h
reaction
hand
signific
activ
detect
uracil
araura
dideoxyuridin
ddurd
evalu
short
reaction
time
h
therefor
subsequ
assay
perform
use
durd
nucleosid
sugar
donor
known
g
stearothermophilu
np
enzym
catalyz
revers
phosphorolyt
cleavag
nglycosid
bond
nucleosid
form
free
base
respect
activ
pentos
moieti
coupl
desir
modifi
base
yield
nucleosid
analogu
enzym
involv
nucleosid
salvag
pathway
express
differ
growth
phase
may
vari
reason
biosynthesi
evalu
differ
stage
microorgan
growth
fig
reaction
quantit
analyz
hplc
describ
product
character
perform
mshplc
use
thermo
finnigan
spectromet
electron
spray
ioniz
method
esi
one
ion
trap
detector
experiment
best
convers
achiev
cultur
earli
stationari
phase
h
therefor
follow
assay
grew
g
stearothermophilu
strain
phase
previous
shown
temperatur
influenc
enzym
activ
thu
effect
evalu
convers
reaction
therefor
biosynthesi
perform
fig
best
convers
valu
obtain
temperatur
lower
optimum
temperatur
growth
microorgan
base
obtain
result
observ
hydrolas
activ
chlorin
atom
reaction
carri
high
temperatur
decreas
convers
similar
yield
obtain
due
oper
facil
requir
select
temperatur
subsequ
trial
differ
reaction
variabl
test
order
optim
reaction
paramet
obtain
purin
nucleosid
import
presenc
phosphat
reaction
nucleosid
phosphorolysi
np
previous
report
preliminari
test
perform
optim
differ
phosphat
concentr
mm
ph
valu
stir
speed
rpm
signific
differ
observ
among
sever
paramet
see
supplementari
data
therefor
decid
use
mm
potassium
phosphat
buffer
ph
rpm
standard
condit
wide
report
transglycosyl
reaction
revers
shown
excess
substrat
improv
transglycosyl
studi
biosynthesi
presenc
excess
base
excess
nucleosid
donor
durd
equal
molar
quantiti
fig
lower
yield
product
obtain
equimolar
quantiti
substrat
use
product
mmh
mm
ratio
evalu
howev
excess
base
test
mm
ratio
product
increas
significantli
mmh
biosynthesi
differ
growth
stage
g
stearothermophilu
grown
media
contain
gl
meat
pepton
gl
yeast
extract
gl
nacl
gl
glucos
ph
cfu
collect
sever
time
biosynthesi
carri
h
reaction
ml
potassium
phosphat
buffer
mm
ph
rpm
use
mm
mm
durd
substrat
reaction
perform
three
time
convers
calcul
mmol
productmmol
limit
reagent
signific
differ
respect
growth
time
p
differ
could
due
excess
shift
equilibrium
favor
format
sinc
modifi
base
compet
effect
natur
purin
within
microorgan
reaction
paramet
optim
evalu
biosynthesi
differ
purin
riboand
deoxyribosid
use
starter
purin
base
durd
urd
sugar
donor
quantit
analysi
carri
hplc
product
identif
perform
mshplc
mention
condit
abl
obtain
accept
product
subsequ
bioprocess
scaleup
howev
higher
convers
obtain
durd
use
sugar
donor
instead
urd
deoxyribosid
hydrolysi
greater
g
stearothermophilu
strain
abl
synthes
purin
ribosid
deoxyribosid
convers
greater
case
tabl
presenc
two
pnp
pnpi
pnpii
g
stearothermophilu
could
account
accept
differ
purin
base
conclus
abl
prepar
broad
spectrum
differ
purin
nucleosid
analogu
reach
signific
product
entrap
techniqu
wide
use
microorgan
stabil
allow
reus
biocatalyst
differ
agaros
polyacrylamid
concentr
assay
g
stearothermophilu
immobil
previous
describ
rivero
col
minimum
matrix
percentag
prevent
microorgan
releas
reaction
medium
assess
optimum
percentag
agaros
polyacrylamid
immobil
respect
thermophil
microorgan
success
immobil
agaros
polyacrylamid
obtain
h
h
convers
respect
observ
immobil
biocatalyst
requir
longer
time
free
microorgan
reach
success
convers
valu
well
known
differ
relat
diffus
restrict
matric
final
agaros
matrix
select
subsequ
test
g
stearothermophilu
immobil
agaros
stabl
month
storag
condit
could
reus
least
time
without
signific
loss
activ
retain
activ
reach
mgl
free
microorgan
stabl
day
lost
activ
less
initi
activ
reus
see
supplementari
data
select
biocatalyst
perform
preliminari
test
bioprocess
scaleup
trial
conduct
ml
batch
reactor
condit
previous
optim
result
similar
obtain
microscal
current
environment
factor
efactor
valu
produc
compound
pharmaceut
compani
vari
howev
use
safe
microorgan
characterist
matrix
simpl
recoveri
excess
substrat
favor
efactor
decreas
report
new
green
bioprocess
purin
nucleosid
product
describ
direct
transglycosyl
use
g
stearothermophilu
cetc
immobil
agaros
matrix
biocatalyst
meet
requir
high
activ
stabil
short
reaction
time
need
low
cost
product
futur
prepar
applic
use
environment
friendli
methodolog
